Real-World Evaluation of an Injectable Treatment Containing Polynucleotides Purified with High Purification Technology (PN HPT) and Hyaluronic Acid for Skin Quality Improvement in Facial and Body Areas

Polynucleotides purified through High Purification Technology (PN HPT), combined with hyaluronic acid (HA), represent a novel injectable strategy to improve skin quality in aesthetic medicine. This real-world data collection aimed to evaluate the safety and performance of PN HPT-based treatments across multiple facial and body areas. Data were collected through a post-market clinical follow-up survey, analysing 218 questionnaires completed after 654 intradermal infiltrations performed on the face (e.g., forehead, perioral lines, crow’s feet), neck, hands, and décolleté. Aesthetic outcomes were assessed using clinician- and patient-reported Global Aesthetic Improvement Scale and Global Clinical Improvement Scale scores. Safety and satisfaction were evaluated through adverse event reporting and a patient-completed Likert scale. Across all treated areas, consistent improvement was observed. For the face, 39% of cases achieved “marked improvement” or “excellent result” on the GCI-S, with 48% rated as “much improved” or “very much improved” on the GAIS. Similar outcomes were reported for the neck (41% and 57%), hands (31% and 41%), and décolleté (43% and 55%). Patient satisfaction was high, with over 90% expressing general satisfaction and willingness to repeat the treatment. No serious or unexpected adverse events occurred. These findings suggest that PN HPT and HA injectables may offer a high level of patient satisfaction, observable improvements in skin quality, and a favorable safety profile in the modern aesthetic practice.